angiotensin ii, des-phe(8)- has been researched along with Cognitive Decline in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors | Studies |
---|---|
Billheimer, D; Doyle, KP; Hay, M; Hoyer-Kimura, C; Konhilas, JP; Mansour, HM; Polt, R | 1 |
Duan, R; E, Y; Gong, PY; Jiang, T; Wang, SY; Xue, X; Zhang, QQ; Zhang, YD | 1 |
Garabadu, D; Varshney, V | 1 |
Bartlett, MJ; Doyle, KP; Falk, T; Hay, M; Heien, ML; Konhilas, JP; Largent-Milnes, TM; Polt, R; Rodgers, K; Vanderah, TW | 1 |
Cao, C; Hasegawa, Y; Hayashi, K; Kim-Mitsuyama, S; Takemoto, Y | 1 |
Barnes, CA; Constantopoulos, E; Hay, M; Konhilas, J; Samareh-Jahani, F; Uprety, AR; Vanderah, TW | 1 |
6 other study(ies) available for angiotensin ii, des-phe(8)- and Cognitive Decline
Article | Year |
---|---|
Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia.
Topics: Angiotensin I; Animals; Biomarkers; Cognitive Dysfunction; Cytokines; Dementia, Vascular; Male; Mice; Mice, Inbred C57BL; Neurofilament Proteins; Peptide Fragments; Prognosis; Stroke Volume | 2021 |
ACE2 activator diminazene aceturate ameliorates Alzheimer's disease-like neuropathology and rescues cognitive impairment in SAMP8 mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Brain Chemistry; Cognitive Dysfunction; Cytokines; Diminazene; Infusions, Parenteral; Male; Maze Learning; Mice; Mice, Neurologic Mutants; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; tau Proteins | 2020 |
Ang(1-7) exerts Nrf2-mediated neuroprotection against amyloid beta-induced cognitive deficits in rodents.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin I; Animals; Behavior, Animal; Cognitive Dysfunction; Disease Models, Animal; Heme Oxygenase (Decyclizing); Hippocampus; Infusions, Intraventricular; Male; Maze Learning; Mitochondria; Neuroprotective Agents; NF-E2-Related Factor 2; Peptide Fragments; Rats; Rats, Wistar; Signal Transduction; Treatment Outcome | 2021 |
A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction.
Topics: Angiotensin I; Animals; Behavior, Animal; Biomarkers; Brain; Cognitive Dysfunction; Dementia, Vascular; Electrocardiography; Glycosylation; Half-Life; Heart Failure; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Maze Learning; Memory; Mice; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Spatial Memory; Ventricular Remodeling | 2019 |
Chronic Angiotensin 1-7 Infusion Prevents Angiotensin-II-Induced Cognitive Dysfunction and Skeletal Muscle Injury in a Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Body Weight; Cerebrovascular Circulation; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Maze Learning; Mice; Muscle, Skeletal; Peptide Fragments; Rotarod Performance Test | 2019 |
Cognitive impairment in heart failure: A protective role for angiotensin-(1-7).
Topics: Angiotensin I; Animals; Cognitive Dysfunction; Disease Models, Animal; Heart Failure; Inflammation; Male; Maze Learning; Mice; Mice, Inbred C57BL; Myocardial Infarction; Peptide Fragments; Ventricular Remodeling; Visual Acuity | 2017 |